SAN FRANCISCO--(BUSINESS WIRE)--Today, Limbix, a prescription digital therapeutic company developing treatments for adolescent mental health disorders, announced it has raised $15 million in Series A2 ...

Big Health, a maker of digital therapeutics, announced it was acquiring Limbix, creator of digital therapeutics for adolescents. The acquisition marks Big Health’s first entry into the adolescent ...

Digital therapeutics company Big Health announced it acquired Limbix, a maker of prescription digital therapeutics aimed at treating depression in teens and young adults. Limbix is the creator of ...

In October, Limbix, a company creating digital therapeutics for adolescents, released data from a trial on its new product: SparkRx. SparkRx is a self-guided therapy program for teens run entirely on ...

One of the most important applications of digital therapeutics is in mental health, and with millions of Americans stuck at home due to the Covid-19 pandemic, that potential use has come to the fore ...

Limbix, maker of a prescription digital therapeutic aimed at treating depression in teens, scooped up $15 million in Series A2 funding. The round was led by GSR Ventures, with participation from ...

Big Health, one of the leading companies producing apps to help treat mental health conditions, on Thursday announced it acquired Limbix, developer of a prescription app for adolescent depression. The ...

SAN FRANCISCO & NASHVILLE, Tenn.--(BUSINESS WIRE)--Limbix, a developer of digital therapeutics focused on adolescent mental health treatment, and BehaVR, LLC, a leading innovator of virtual reality ...

Please provide your email address to receive an email when new articles are posted on . Prescription digital therapeutic company Limbix announced the launch of a digital tool for teens and young ...

Limbix is moving ahead with plans to file for FDA approval of its SparkRx digital therapeutic (DTx) for adolescents with symptoms of depression after reporting positive results in a clinical trial.